Why Medical Treatment Sourcing Matters: The Real Risks of Buying From Unregulated Sellers
Quick answer: Independent laboratory testing has repeatedly found that medical treatments bought from unverified, low-cost online sellers frequently don't match their label — wrong purity, wrong dose, wrong compound entirely, or contamination with bacterial endotoxins. In South Africa, SAHPRA has gone as far as issuing public warnings about unregistered medical treatment products sold through websites and social media. Buying from a regulated, doctor-run supplier that compounds through a SAPC-compliant pharmacy — with batch-specific, third-party Certificates of Analysis (COAs) — is the single most effective way to avoid these risks.
The medical treatment market has outgrown its oversight
Medical Treatment use has moved from a niche research interest into a mainstream retail category in just a few years, with products now sold everywhere from specialty clinics to general e-commerce marketplaces and social-media sellers. That expansion has happened alongside a well-documented pattern of mislabeling, incorrect dosing, and contamination in a substantial share of samples pulled from unverified sellers.
South Africa's regulator has taken notice. In November 2024, the South African Health Products Regulatory Authority (SAHPRA) issued a formal position on the proliferation of falsified, compounded, and substandard appetite-regulating medicines (semaglutide and tirzepatide) being sold to the public via websites and social media. SAHPRA's position is unambiguous: compounding a medicine using an active ingredient that is not contained in a product registered with SAHPRA is illegal under the Medicines and Related Substances Act. In May 2026, SAHPRA and the South African Pharmacy Council (SAPC) jointly announced a crackdown on the unlawful manufacturing of unregistered appetite-regulating medicines.
SAHPRA has also published a dedicated public warning on medical treatment products specifically — naming BPC-157, TB-500, Melanotan II, CJC-1295, Ipamorelin, PT-141, AOD-9604, Selank, and Semax as examples of medical treatments being unlawfully marketed in South Africa. The warning is clear that these products have not been reviewed by SAHPRA for quality, safety, or efficacy.
The takeaway isn't that medical treatments themselves are inherently dangerous — many have decades of legitimate clinical research behind them. The problem is where and how they're being sourced.
What independent testing actually finds
This isn't a theoretical concern. Multiple independent testing initiatives — several of them directly relevant to products circulating in South Africa — have quantified exactly how often unregulated medical treatment products fail to meet basic quality standards.
Widespread purity and identity failures. A large-scale review of thousands of gray-market medical treatment samples — covering commonly sought compounds — found that a substantial minority of tested batches simply didn't contain the active ingredient the label claimed at all, and that depending on which quality benchmark was applied, somewhere between roughly 42% and 71% of samples failed to meet basic purity or quality criteria, with measurable bacterial endotoxin contamination showing up as well.
Purity levels far below what's claimed. While pharmaceutical-grade material is generally required to sit at 98% purity or higher, independent testing on gray-market batches has repeatedly turned up purity levels as low as 60–85% — meaning up to 40% of the vial can be synthesis byproducts, truncated fragments, or other impurities never disclosed to the buyer.
Some cases far worse than "low purity." Independent journalism testing has documented extreme outliers. One 2024 investigation identified samples testing below 8% purity — essentially a vial of filler sold as a full-strength compound. A separate lab-testing investigation that purchased medical treatments across several vendor tiers found that 3 of 10 samples sent for independent testing failed outright on purity, identity, or contamination grounds.
Contamination is not a rare edge case. A published analysis of grey-market semaglutide products — the very class SAHPRA has warned the South African public about — found samples testing at 7.7% to 14.37% purity against a labeled claim of 99%, with every single sample in the study testing positive for bacterial endotoxins. Endotoxins are byproducts that can trigger fever, dangerously low blood pressure, or serious immune reactions when injected. A separate forensic analysis of seized falsified medical treatment products in Europe found purity ranging from just 5% to 75%, with over a quarter of samples containing arsenic or other undisclosed contaminants.
Self-reported paperwork can't be trusted. Perhaps most importantly for buyers trying to do their due diligence: certificates of analysis generated by a seller's own in-house lab — rather than an accredited independent laboratory — have been documented overstating purity by more than ten percentage points. A COA is only meaningful when it comes from a party with no financial interest in the result.
Why this happens: an unpoliced supply chain
Much of the gray market relies on a regulatory loophole that was never intended for human medicines. Products sold as "research chemicals" or labelled "not for human use" are legal to sell for research purposes, unapproved for human use, and — critically — largely unpoliced for manufacturing quality. In this market a buyer can purchase a vial from a company operating in the open with a Certificate of Analysis that no regulator has ever actually reviewed.
That structure creates predictable failure points:
- No mandatory testing floor. Nothing requires an unregistered seller to test every batch, let alone publish the results.
- No sterility requirement. Injectable products made outside a licensed, SAPC-compliant compounding pharmacy with a cleanroom carry meaningfully higher contamination risk.
- No accountability for mislabeling. A vial can say "99% pure" with no consequence if it isn't.
- No medical oversight. There's no clinician reviewing your health history, checking for contraindications, or verifying you're using an appropriate product for your situation.
- No recourse. If a product harms you or simply doesn't contain what it claims, an anonymous online seller offers little to no path to accountability.
SAHPRA's position is direct on this point: medicines that have not been registered with the authority have not been reviewed for quality, safety, or efficacy — and compounding a medicine using an unregistered active ingredient is unlawful under South African law.
What separates a reputable medical treatment supplier from the rest
Not every medical treatment seller carries this risk. The difference between a trustworthy source and a liability comes down to a small number of verifiable factors:
1. SAPC-compliant compounding
Medical Treatments for human use should be compounded by a licensed pharmacy that complies with South African Pharmacy Council standards and Good Pharmacy Practice — ideally one with a HEPA-filtered cleanroom for sterile preparations and licensed pharmacists holding specialised compounding certification.
2. Independent, batch-specific testing
Every batch should ship with a Certificate of Analysis from an accredited third-party laboratory — not the seller's own equipment — confirming identity, purity, and the absence of contaminants like bacterial endotoxins and heavy metals.
3. Medical oversight
A legitimate supplier operates under licensed physician involvement: reviewing appropriateness for the individual, screening for contraindications, and providing a point of clinical contact rather than a faceless storefront.
4. Regulatory compliance
Reputable companies operate transparently within the applicable South African regulatory framework rather than skirting it with vague "research use only" disclaimers while marketing directly for human use — the exact pattern SAHPRA and the SAPC have been cracking down on.
5. Manufacturing transparency
You should be able to identify where and how a product is made — ideally at a facility that follows current Good Manufacturing Practice (cGMP) standards — rather than an unnamed synthesis lab overseas.
6. Traceability
Lot numbers, testing dates, and the identity of the testing laboratory should all be disclosed and verifiable, not just asserted.
7. A real, accountable business
Verifiable business registration, a physical presence, real customer support, and a track record — not just a storefront that could disappear tomorrow.
Red flags to watch for
- No COA offered, or a COA that isn't from an independent, named laboratory
- Prices dramatically below the market average (quality testing and cGMP manufacturing cost money — rock-bottom pricing is often a sign both are being skipped)
- Vague or missing information about where the product is compounded or manufactured
- Marketing language aimed squarely at human self-administration while the product is labelled "not for human use" or "research use only"
- No licensed clinician involved anywhere in the process
- No verifiable business identity, physical address, or customer support channel
How to vet any medical treatment supplier before you buy
- Ask for the COA — and check who issued it. It should come from an accredited, independent lab, not the seller.
- Confirm medical oversight exists. Is a licensed physician actually involved in reviewing orders, or is this a checkout page with no clinical review?
- Check the compounding source. Is the product compounded by a SAPC-compliant pharmacy with a cleanroom, or made in an unverified facility?
- Look up regulatory red flags. A quick search of the company alongside "SAHPRA" or "unregistered" is worth the two minutes it takes.
- Evaluate the business itself. Registered company, real contact information, transparent pricing, and a support team you can actually reach.
Frequently asked questions
Are medical treatments bought online safe? Safety depends almost entirely on the source. Medical Treatments from independently tested, medically supervised, regulation-compliant suppliers carry a very different risk profile than those from anonymous gray-market sellers, where independent testing has repeatedly found purity, identity, and contamination failures. SAHPRA has specifically warned the South African public about unregistered medical treatment products sold online.
What is a Certificate of Analysis (COA), and why does it matter? A COA is a lab report confirming a product's identity, purity, and contaminant levels for a specific batch. It only carries weight when issued by an independent, accredited laboratory — a seller's self-generated COA has been documented to overstate purity significantly.
Why are some medical treatment sellers so much cheaper than others? Third-party testing, cGMP-compliant manufacturing, sterile cleanroom compounding, and medical oversight all add real cost. Prices far below the market typically mean one or more of these steps has been skipped.
Is it legal to buy medical treatments for personal use in South Africa? Medical Treatment legality in South Africa is governed by the Medicines and Related Substances Act and SAHPRA's registration framework. Compounding a medicine using an active ingredient not contained in a product registered with SAHPRA is unlawful. Reputable suppliers operate transparently within this framework rather than relying on "research use only" labelling to sidestep it.
What should I look for in a reputable medical treatment supplier? SAPC-compliant compounding, batch-specific third-party COAs, licensed physician oversight, transparent sourcing, and a verifiable, accountable business — not just a checkout page.
The bottom line
The data is consistent across every independent testing initiative that's looked at this market: unregulated medical treatment sourcing carries real, quantifiable risk — not hypothetical risk. Purity failures, mislabeling, and contamination aren't rare exceptions; in some testing samples, they're closer to the norm.
At Ambrosia, medical treatments are compounded through a SAPC-compliant pharmacy operating HEPA-filtered cleanroom facilities, with licensed pharmacist oversight, batch traceability, and independent lab verification — rather than being left to an anonymous supply chain. That's not a marketing claim — it's the operational difference between a supplier you can verify and one you're simply trusting.
This article is for general educational purposes and is not medical advice. Consult a licensed healthcare provider before starting any medical treatment protocol.
